Mirae Asset Global Investments Co. Ltd. acquires new stakes in West Pharmaceutical Services, Inc. (NYSE: WST)


Mirae Asset Global Investments Co. Ltd. acquired a new stake in West Pharmaceutical Services, Inc. (New York Stock Exchange: WSTGet a rating) during the first quarter, according to its last disclosure to the SEC. The company bought 10,741 shares of the medical device supplier’s stock, valued at around $4,412,000.

Other hedge funds and other institutional investors have also been buying and selling shares of the company recently. BlackRock Inc. increased its stake in West Pharmaceutical Services by 8.9% in the fourth quarter. BlackRock Inc. now owns 8,094,288 shares of the medical device supplier valued at $3,796,302,000 after acquiring an additional 664,275 shares in the last quarter. State Street Corp increased its stake in West Pharmaceutical Services by 1.6% in the fourth quarter. State Street Corp now owns 3,455,709 shares of the medical device supplier valued at $1,620,762,000 after acquiring an additional 54,510 shares in the last quarter. WCM Investment Management LLC increased its stake in West Pharmaceutical Services by 0.8% in the 1st quarter. WCM Investment Management LLC now owns 1,526,481 shares of the medical device supplier valued at $626,941,000 after acquiring 11,655 additional shares in the last quarter. Geode Capital Management LLC increased its stake in West Pharmaceutical Services by 3.0% in the 4th quarter. Geode Capital Management LLC now owns 1,382,016 shares of the medical device supplier valued at $646,546,000 after acquiring 40,280 additional shares in the last quarter. Finally, Northern Trust Corp increased its stake in West Pharmaceutical Services by 0.5% in the 4th quarter. Northern Trust Corp now owns 970,724 shares of the medical device supplier valued at $455,279,000 after acquiring an additional 5,206 shares in the last quarter. 93.25% of the shares are held by hedge funds and other institutional investors.

West Pharmaceutical Services shares down 2.5%

Shares of NYSE WST opened at $311.47 on Tuesday. The company has a 50-day simple moving average of $313.71 and a 200-day simple moving average of $342.69. The company has a market capitalization of $23.06 billion, a P/E ratio of 34.57, a P/E/G ratio of 1.29 and a beta of 1.15. The company has a debt ratio of 0.09, a current ratio of 3.13 and a quick ratio of 2.41. West Pharmaceutical Services, Inc. has a 1-year low of $275.89 and a 1-year high of $475.35.

Western Pharmaceutical Services (New York Stock Exchange: WSTGet a rating) last announced its quarterly results on Thursday, July 28. The medical device supplier reported earnings per share (EPS) of $2.47 for the quarter, beating analysts’ consensus estimate of $2.19 by $0.28. The company posted revenue of $771.30 million in the quarter, versus a consensus estimate of $754.25 million. West Pharmaceutical Services achieved a net margin of 23.41% and a return on equity of 29.08%. The company’s revenues increased by 6.6% compared to the same quarter last year. In the same quarter last year, the company achieved EPS of $2.46. On average, stock research analysts expect West Pharmaceutical Services, Inc. to post earnings per share of 9.13 for the current year.

Analyst upgrades and downgrades

Separately, StockNews.com downgraded shares of West Pharmaceutical Services from a “buy” rating to a “hold” rating in a report on Thursday, April 28.

Insider buying and selling

In related news, insider Silji Abraham sold 5,374 shares in a trade that took place on Monday, August 1. The shares were sold at an average price of $343.93, for a total transaction of $1,848,279.82. Following the completion of the transaction, the insider now owns 3,201 shares of the company, valued at approximately $1,100,919.93. The transaction was disclosed in a filing with the Securities & Exchange Commission, accessible via the SEC website. 0.60% of the shares are currently held by company insiders.

Western Pharmacy Services Profile

(Get a rating)

West Pharmaceutical Services, Inc. designs, manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, Middle East, Africa and Asia-Pacific. It operates in two segments, Proprietary Products and Contract Manufactured Products.

Featured Articles

Want to see which other hedge funds hold WSTs? Visit HoldingsChannel.com for the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (New York Stock Exchange: WSTGet a rating).

Institutional ownership by quarter for West Pharmaceutical Services (NYSE:WST)



Get daily news and reviews for West Pharmaceutical Services – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for West Pharmaceutical Services and related companies with MarketBeat.com’s free daily email newsletter.